Lisofylline inhibitor of phosphatidic acid data

CTIC announced results of a double-blind Phase II trial of lisofylline along with high dose induction chemotherapy in 70 patients with newly diagnosed acute

Read the full 241 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE